Menu

Vylor, Franco-Nevada On Deck Wednesday As New Coverage, Gold Prices Face Test

Benzinga Insights 1 hour ago

Earnings

Vylor headlines Wednesday’s reports as investors assess how the newly covered consumer-staples company will be received, while Franco-Nevada offers a read on precious-metals exposure after a strong stock run. CGI, ICL

Vylor headlines Wednesday’s reports as investors assess how the newly covered consumer-staples company will be received, while Franco-Nevada offers a read on precious-metals exposure after a strong stock run. CGI, ICL Group, RUM Group and Boyd Group Services report before the open; Franco-Nevada, Vylor, Tetra Tech, CAE, Corteva and OR Royalties report after the close.

Key Reports Before The Bell

CGI (NYSE:GIB) — Q4 — 6:30 a.m. ET

  • EPS: $1.64 est. vs. $1.55 a year ago (+6%)
  • Revenue: $2.93 billion est. vs. $2.92 billion a year ago (+1%)
  • Stock: +16.3% past month, -10.9% YTD, 13.7% below its 52-week high
  • Analyst view: Hold, $100 target (1 analyst)

CGI has beaten estimates in five of its past eight quarters, but the setup is less forgiving after its most recent miss and a recent rebound in the stock. In Q3, it missed on both EPS and revenue. On its July call, management pointed to acquisition-led growth and strong financial-services performance in North America, with rising AI demand supporting its outlook.

ICL Group (NYSE:ICL) — Q3 — 2:10 a.m. ET

  • EPS: $0.10 est. vs. $0.10 a year ago
  • Revenue: $0.43 billion est. vs. $1.85 billion a year ago (-77%)
  • Stock: -6.0% past month, -18.7% YTD, 33.5% below its 52-week high
  • Analyst view: Hold, $6 target (1 analyst)

ICL Group has beaten estimates in six of its past eight quarters, while the stock’s retreat and the sharp revenue comparison make execution on its efficiency plan the central issue. In Q2, it beat on both EPS and revenue. On its August call, management outlined a new organizational structure and the Elevate cost program, which is intended to produce substantial annual EBITDA improvement by 2028.

RUM Group (NASDAQ:RUM) — Q3 — 8:00 a.m. ET

  • EPS: -$0.13 est. vs. -$0.06 a year ago (wider loss)
  • Revenue: $88.8 million est. vs. $24.8 million a year ago (+259%)
  • Stock: -26.0% past month, -19.9% YTD, 51.8% below its 52-week high
  • Analyst view: Hold, $25 target (1 analyst)

RUM Group has beaten estimates in just one of its past eight quarters, with the stock under pressure as investors weigh growth investments against continued losses. In Q2, it missed on EPS but beat revenue. On its August call, management highlighted the Northern Data acquisition and Quake AI as part of its effort to expand its AI infrastructure.

Boyd Group Services (NYSE:BGSI) — Q3 — 6:00 a.m. ET

  • EPS: $0.87 est. vs. $0.62 a year ago (+40%)
  • Revenue: $1.02 billion est. vs. $0.79 billion a year ago (+29%)
  • Stock: +12.7% past month, -44.7% YTD, 51.9% below its 52-week high
  • Analyst view: Strong Buy, $120 target (1 analyst)

Boyd Group Services enters the report after a steep year-to-date decline despite a recent bounce, putting the focus on whether its acquisition synergies can translate into durable operating improvement. In Q2, it missed on both EPS and revenue. On its August call, management said revenue had surpassed $1 billion for the first time and highlighted a higher synergy target.

Key Reports After The Bell

Franco-Nevada (NYSE:FNV) — Q3 — 5:30 p.m. ET

  • EPS: $1.74 est. vs. $1.43 a year ago (+22%)
  • Revenue: $552.3 million est. vs. $487.7 million a year ago (+13%)
  • Stock: +4.3% past month, +23.6% YTD, 10.5% below its 52-week high
  • Analyst view: Buy consensus, $271 target (6 analysts)

Franco-Nevada has beaten estimates in six of its past eight quarters, and the report will test whether strong commodity prices and higher production can extend the stock’s gains. In Q2, it missed on both EPS and revenue. On its August call, management said higher production and new assets were lifting gold-equivalent ounces sold and kept the company on track for the upper half of its annual guidance. RBC Capital maintained its Outperform rating while raising its target to $300 from $285 in September.

Vylor (NYSE:VYLR) — Q3 — 4:00 p.m. ET

  • EPS: -$0.50 est.
  • Revenue: $903.7 million est.
  • Stock: -4.1% past month, 6.2% below its 52-week high
  • Analyst view: Buy consensus, $83 target (9 analysts)

The consumer-staples company is entering a report shaped by a wave of new analyst coverage, making the market’s initial read on its operating profile the key question. BNP Paribas initiated coverage at Neutral with a $75 target in October.

Tetra Tech (NASDAQ:TTEK) — Q4 — 4:00 p.m. ET

  • EPS: $0.47 est. vs. $0.44 a year ago (+7%)
  • Revenue: $1.15 billion est. vs. $1.33 billion a year ago (-14%)
  • Stock: +21.4% past month, +21.2% YTD, 5.7% below its 52-week high
  • Analyst view: Strong Buy, $42 target (2 analysts)

Tetra Tech has beaten estimates in all of its past eight quarters, leaving backlog conversion and cash-flow execution as the main tests for a stock that has climbed sharply in the past month. In Q3, it beat on both EPS and revenue. On its July call, management pointed to revenue above guidance, record cash flow and a $200 million backlog increase. RBC Capital maintained its Outperform rating while lowering its target to $44 from $46 in October.

CAE (NYSE:CAE) — Q2 — 4:00 p.m. ET

  • EPS: $0.19 est. vs. $0.17 a year ago (+12%)
  • Revenue: $907.7 million est. vs. $898.5 million a year ago (+1%)
  • Stock: +16.7% past month, -9.0% YTD, 19.2% below its 52-week high
  • Analyst view: Buy consensus, $37 target (3 analysts)

CAE has beaten estimates in seven of its past eight quarters, but the report must show that its defense and civil-market strategy can overcome recent pressure on operating income. In Q1, it beat on both EPS and revenue. On its August call, management described a strong start to fiscal 2027 while acknowledging a decline in adjusted segment operating income. RBC Capital upgraded the stock to Outperform from Sector Perform and raised its target to $46 from $36 in August.

Corteva (NYSE:CTVA) — Q3 — 4:30 p.m. ET

  • EPS: $0.09 est. vs. -$0.23 a year ago (swing to profit)
  • Revenue: $1.77 billion est. vs. $2.62 billion a year ago (-32%)
  • Stock: -8.6% past month, +20.9% YTD, 86.7% below its 52-week high
  • Analyst view: Buy consensus, $75 target (12 analysts)

Corteva has beaten estimates in seven of its past eight quarters, but the upcoming print faces a difficult revenue comparison and the added complexity of its separation preparations. In Q2, it beat on EPS but missed revenue. On its July call, management cited stronger execution in seeds and crop protection and raised its full-year outlook. UBS maintained its Neutral rating while lowering its target to $15 from $90 in October.

OR Royalties (NYSE:OR) — Q3 — 4:35 p.m. ET

  • EPS: $0.27 est. vs. $0.22 a year ago (+23%)
  • Revenue: $90.1 million est. vs. $71.6 million a year ago (+26%)
  • Stock: +5.1% past month, +3.0% YTD, 23.9% below its 52-week high
  • Analyst view: Buy consensus, $41 target (3 analysts)

OR Royalties has beaten estimates in four of its past eight quarters, with investors watching whether acquisitions and higher gold-equivalent ounces can offset operational challenges at key assets. In Q2, it missed on both EPS and revenue. On its August call, management highlighted its royalty-portfolio acquisitions and affirmed its annual gold-equivalent-ounce guidance. RBC Capital maintained its Outperform rating while raising its target to $47 from $45 in September.

Also Reporting Before The Bell

Plus 12 companies valued between $100 million and $2 billion, including Applied Aerospace & Defense, Nayax and Flex LNG.

Also Reporting After The Bell

  • Ultrapar Participacoes (NYSE:UGP) — $0.28 EPS on $8.58 billion revenue
  • EnerSys (NYSE:ENS) — $3.18 EPS on $966.8 million revenue
  • Okeanis Eco Tankers (NYSE:ECO) — $3.69 EPS on $220.2 million revenue
  • Teekay Tankers (NYSE:TNK) — $4.29 EPS on $263.5 million revenue
  • Digi International (NASDAQ:DGII) — $0.75 EPS on $140.3 million revenue
  • Pelagos Insurance Capital (NYSE:PLGO) — $0.72 EPS on $710.2 million revenue
  • Lakefront Biotherapeutics (NASDAQ:LKFT) — -$0.19 EPS on $8.7 million revenue

Plus 15 companies valued between $100 million and $2 billion, including EZCORP, Alvotech and Adecoagro.

See the full Benzinga earnings calendar

Read the original